Related Experiment Videos

[Effect of fosfomycin on auditory organs and its transfer to cochlear lymph following application of its solution

Insights

Fosfomycin (FOM) ototopical solution showed concentration-dependent transfer into cochlear lymph in guinea pigs, with a longer half-life than kanamycin (KM). No significant hair cell damage was observed with FOM treatment.

Area of Science:

  • Ototopical drug delivery and pharmacokinetics
  • Otolaryngology and audiology research
  • Antibiotic efficacy and safety studies

Context:

  • Middle ear infections require effective drug delivery to the inner ear.
  • Understanding antibiotic penetration into cochlear lymph is crucial for treating inner ear infections.
  • Ototopical solutions are a potential route for delivering therapeutics to the inner ear.

Purpose:

  • To evaluate the transfer of fosfomycin (FOM) from the middle ear cavity to the cochlear lymph in guinea pigs.
  • To compare the pharmacokinetic profile of FOM with kanamycin (KM) in the cochlear lymph.
  • To assess the ototoxicity of FOM ototopical solutions on cochlear hair cells.

Summary:

  • Male guinea pigs received ototopical fosfomycin (FOM) or kanamycin (KM) solutions. Cochlear lymph was analyzed for antibiotic concentrations, revealing FOM's concentration-dependent transfer and a longer half-life (4.8 hours) compared to KM (2.3 hours).
  • Peak FOM concentration in cochlear lymph was lower than KM, but the area under the curve (AUC) for 3% FOM was higher, indicating sustained exposure.
  • Scanning electron microscopy revealed no significant correlation between FOM treatment and damage to outer or inner hair cells, suggesting a favorable safety profile.

Impact:

  • This study provides critical pharmacokinetic data for FOM ototopical solutions, informing potential therapeutic strategies for inner ear infections.
  • The findings suggest FOM may offer a viable treatment option for otitis media with potential inner ear involvement.
  • Demonstrates the importance of assessing drug transfer and ototoxicity for developing safe and effective ototopical therapies.

Related Concept Videos